Quantinosis.ai LLC: Clinical Trials

1 trial sponsored by Quantinosis.ai LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Quantinosis.ai LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19)
N-acetyl glucosamine (NAG), Control - Coronavirus, Covid19
Phase 1CompletedQuantinosis.ai LLC1502020-11-142023-04-04

Conditions studied

COVID-19 (1)  ·  Coronavirus Infections (1)

Interventions

Acetylglucosamine (1)

Countries

United States (1)

Results publications

PMID 34306677